Atherton Lane Advisers’s Amgen AMGN Stock Holding History

Atherton Lane Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$34.6M	Buy	213,291 +3,035	+1%	+$477K	2.02%	10
2015 Q3	$29.1M	Buy	210,256 +4,250	+2%	+$670K	1.82%	14
2015 Q2	$31.6M	Buy	206,006 +2,985	+1%	+$478K	1.75%	14
2015 Q1	$32.5M	Buy	203,021 +2,795	+1%	+$440K	1.75%	8
2014 Q4	$31.9M	Buy	200,226 +195	+0.1%	+$30.4K	1.75%	10
2014 Q3	$28.1M	Sell	200,031 -2,297	-1%	-$300K	1.6%	13
2014 Q2	$23.9M	Buy	202,328 +4,075	+2%	+$472K	1.33%	29
2014 Q1	$24.5M	Buy	198,253 +3,845	+2%	+$466K	1.51%	26
2013 Q4	$22.2M	Buy	194,408 +3,074	+2%	+$350K	1.4%	33
2013 Q3	$21.4M	Buy	191,334 +188,311	+6,229%	+$20.4M	1.47%	28
2013 Q2	$298K	Buy	+3,023	New	+$314K	0.02%	113

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Atherton Lane Advisers's AMGN Position: Q4 2015 in Review

Atherton Lane Advisers increased its Amgen (AMGN) stake by 1.4% in Q4 2015, buying an estimated $477K and bringing the position to 213,291 shares worth $34.6M. The position accounts for 2.02% of the portfolio, ranked #10.

Atherton Lane Advisers first reported a position in AMGN in Q2 2013 and has held it in 11 quarters since. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

Atherton Lane Advisers held 213,291 shares of Amgen worth $34.6M as of Q4 2015.
Atherton Lane Advisers bought 3,035 Amgen shares in Q4 2015, an estimated $477K.
Amgen made up 2.02% of Atherton Lane Advisers's portfolio in Q4 2015, its #10 holding.
Atherton Lane Advisers first reported a position in Amgen in Q2 2013 and has held it in 11 quarters since.
1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.